|
CIR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.189600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.498800E-01 |
| Normal-vs-Stage2 |
4.526200E-01 |
| Normal-vs-Stage3 |
3.241600E-01 |
| Normal-vs-Stage4 |
2.041000E-01 |
| Stage1-vs-Stage2 |
1.533610E-01 |
| Stage1-vs-Stage3 |
6.580000E-02 |
| Stage1-vs-Stage4 |
1.460350E-01 |
| Stage2-vs-Stage3 |
8.736400E-01 |
| Stage2-vs-Stage4 |
7.743000E-01 |
| Stage3-vs-Stage4 |
8.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.699400E-01 |
| Normal-vs-AfricanAmerican |
8.197600E-01 |
| Normal-vs-Asian |
5.509800E-01 |
| Caucasian-vs-AfricanAmerican |
2.745800E-01 |
| Caucasian-vs-Asian |
4.686400E-01 |
| AfricanAmerican-vs-Asian |
7.446800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.319810E-01 |
| Normal-vs-Female |
1.654220E-01 |
| Male-vs-Female |
2.740300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.851400E-01 |
| Normal-vs-Extreme_Weight |
1.575230E-01 |
| Normal-vs-Obese |
7.860800E-01 |
| Normal-vs-Extreme_Obese |
5.656200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.416800E-01 |
| Normal_Weight-vs-Obese |
7.160000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.826600E-01 |
| Extreme_Weight-vs-Obese |
2.493600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.362600E-01 |
| Obese-vs-Extreme_Obese |
5.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.979900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.557600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.512000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.042000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.277810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.578300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.347000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.737800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.958800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.330400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.140600E-01 |
| Normal-VS-Type2 PRCC |
3.547600E-01 |
| Normal-VS-KIRP CIMP |
1.999120E-03 |
| Normal-VS-Unclassified PRCC |
8.530600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.544600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.900300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.154600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.002320E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.716800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.487700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.059800E-01 |
| Normal-vs-N1 |
1.987560E-02 |
| Normal-vs-N2 |
1.822790E-01 |
| N0-vs-N1 |
3.942300E-03 |
| N0-vs-N2 |
1.541030E-01 |
| N1-vs-N2 |
6.931800E-01 |
|
|
